Boundless Bio, Inc.
BOLD
$1.13
-$0.04-3.42%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -6.92% | 4.81% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.61% | -5.13% | |||
| Operating Income | 1.61% | 5.13% | |||
| Income Before Tax | 0.53% | 4.20% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.53% | 4.20% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.53% | 4.20% | |||
| EBIT | 1.61% | 5.13% | |||
| EBITDA | 1.64% | 5.33% | |||
| EPS Basic | 0.76% | 4.27% | |||
| Normalized Basic EPS | 0.77% | 4.27% | |||
| EPS Diluted | 0.76% | 4.27% | |||
| Normalized Diluted EPS | 0.77% | 4.27% | |||
| Average Basic Shares Outstanding | 0.25% | 0.07% | |||
| Average Diluted Shares Outstanding | 0.25% | 0.07% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||